Researchers from the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine studied how MRI-linear accelerator imaging can be used to measure tumor changes for 36 patients with glioblastoma. Patients were followed during a six-week course of daily radiation and MRI scans, according to a Sept. 30 news release from the university.
MRI-linear accelerator imaging, also called MRI-linac, was found to signal tumor changes during radiation treatment earlier when compared to standard of care imaging procedures.
The area targeted by radiation treatment could be adjusted based on tumor changes found by the imaging technique, the release said.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
